Lupus clinical trials in Colorado
8 studies for Lupus are looking for participants at sites in Colorado.
Cities in Colorado
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Denver Arthritis Clinic, Denver
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07438496A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Denver Arthritis Clinic - Lowry, Denver
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Sep 17, 2026 · NCT07409181A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- University of Colorado Denver, Aurora
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50719, Aurora
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Sep 4, 2026 · NCT06617325A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- University of Colorado, Aurora
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 21, 2026 · NCT06570798Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- University of Colorado Denver, Aurora
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jul 30, 2026 · NCT05268289Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- University of Colorado Denver, Aurora
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Jul 8, 2026 · NCT06133972A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- GSK Investigational Site, Aurora
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Jun 22, 2026 · NCT06576271From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.